Sanofi Fair Value
SN
The fair market value of SNY stock is 64.36 USD. Relative to the market price of 49.57 USD Sanofi is overvalued by 34.9%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Sanofi Valuation
Current SNY share ticker price is 49.57 USD.
The fair value level of 64.36 USD can be considered as an effective entry point for long-term investors to start investing in SNY stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 35% higher its fair value
Current price is 63% higher its minimum value
Current price is 3% higher its maximum value
Market price:
SNY stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Sanofi SA Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
27.02
2
Median P/E over 5 years
18.2
3
Minimum P/E over 5 years
10.37
4
Earning per share (last 12 months)
3.33 EUR
Maximum value
1
x
4
=
47.91 USD
Fair value
2
x
4
=
32.28 USD
Minimum value
3
x
4
=
18.38 USD
Sanofi SA price metrics
2.97
Annual return (geometric mean)
23.73
Risk (standard deviation) of returns
β
0.56
Beta (volatility compared to market)